Left Atrial Appendage Closure With SentreHeart Lariat® Device

Completed · Not applicable

Conditions studied: Cardioembolic Stroke, Atrial Fibrillation

In brief

The study cohort will consist of up to 50 patients who are candidates for Left Atrial Appendage (LAA) closure in whom oral anticoagulation is contraindicated. Subjects evaluated for left atrial appendage closure will be screened for inclusion and consented prior to their procedure. If the anatomy is favorable for placement of the Lariat® device, the procedure will be performed at one of the participating centers. If anatomy is not favorable, the patient will be excluded from the study and managed using best care practices by his or her physician.

Key facts

Study ID
NCT02681042
Run by
Baylor Research Institute
People needed
9
Starts
2015-03-01
Expected to finish
2018-05-02
Last updated by the study team
2026-02-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.